Infertility
Drug research and approvals for infertility: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 280 studies of infertility are recruiting on ClinicalTrials.gov, Health Canada has authorized 11 drug trials for it since 2013, FDA has 1 approved and 3 open orphan designations naming it, and the EU has 2 authorised medicines for it.
- Recruiting worldwide: 280
- Trials authorized in Canada: 11
- FDA orphan approvals: 1
- EU medicines: 2
- Quality of Life, Decision-making, Resilience, Satisfaction and Success Rate of Different IVF Treatment Strategies: an…NCT07938736 · Not reported · Universitätsklinik fur Frauenheilkunde, Inselspital Bern · starts Jun 1, 2026
- Effect of Sirolimus on Oocyte Quality in Women Undergoing IVFNCT07936227 · Phase 4 · Center for Human Reproduction · starts Feb 25, 2026
- Differential Granulosa Cell Transcriptome Profiling as a Predictive Tool of Ongoing PregnancyNCT07929779 · Not reported · Vida Recoletas Sevilla · starts Dec 10, 2025
- Impact of Infertility on the Sexual Sphere in Couples Undergoing Assisted ReproductionNCT07864935 · Not reported · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · starts Aug 1, 2026
- Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal RespondersNCT07861399 · Not applicable · Al-Azhar University · starts Sep 1, 2026
- Machine-Learning Prediction of Pregnancy Outcomes After Assisted Reproductive TreatmentsNCT07855783 · Not reported · BetaPlus Center for Reproductive Medicine · starts Jan 1, 2026
- Artificial Intelligence in Embryo Selection in Assisted Reproduction for Embryos Cultured to the Fifth Day of…NCT07844083 · Not applicable · University Hospital, Clermont-Ferrand · starts Nov 4, 2024
- Human Sperm Cryopreservation as an Alternative to the Decline of Sperm Quality With AgingNCT07814235 · Not reported · IVI Murcia · starts Jun 10, 2026
- Artificial Intelligence Into Ultrasound Diagnostics in Reproductive MedicineNCT07810920 · Not reported · Semmelweis University · starts Sep 1, 2026
Approved 4
- ClomipheneEstrogen receptor alpha modulator
- Follitropin betaFollicle stimulating hormone receptor agonist
- Choriogonadotropin alfaLuteinizing hormone/Choriogonadotropin receptor agonist
- BromocriptineD2-like dopamine receptor agonist
Phase 3 12 of 39
- Gonadotropin, chorionicLuteinizing hormone/Choriogonadotropin receptor agonist
- MenotropinsLuteinizing hormone/Choriogonadotropin receptor agonist
- ProgesteroneProgesterone receptor agonist
- FollitropinFollicle stimulating hormone receptor agonist
- LetrozoleCytochrome P450 19A1 inhibitor
- Corifollitropin alfaFollicle stimulating hormone receptor agonist
- Follitropin deltaFollicle stimulating hormone receptor agonist
- GanirelixGonadotropin-releasing hormone receptor antagonist
- CetrorelixGonadotropin-releasing hormone receptor antagonist
- GonadorelinGonadotropin-releasing hormone receptor agonist
- Estradiol valerateEstrogen receptor alpha agonist
- Lutropin alfaLuteinizing hormone/Choriogonadotropin receptor agonist
Phase 2 12 of 20
- SomatropinGrowth hormone receptor agonist
- CabergolineDopamine D2 receptor agonist
- FilgrastimGranulocyte colony stimulating factor receptor agonist
- EnclomipheneEstrogen receptor alpha modulator
- AzathioprineAmidophosphoribosyltransferase inhibitor
- LidocaineSodium channel alpha subunit blocker
- SildenafilPhosphodiesterase 5A inhibitor
- HeparinAntithrombin-III activator
- Folic acid
- Dobesilic acid
- NimodipineMineralocorticoid receptor antagonist
- Diosmin
Phase 1 or earlier 10
- Emfilermin
- ErgocalciferolVitamin D receptor agonist
- AZD1981G protein-coupled receptor 44 antagonist
- Isopentyl 2-cyanoacrylate
- PentoxifyllineAdenosine A2 receptor antagonist
- HetastarchPlasma volume expansion
- Levocarnitine
- Zinc sulfate
- Starch
- Vitamin e
How its trials ended
2,437 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 421 whose ending is known, 30% met their primary endpoint, 12% missed it and 58% stopped early.
- Completed, result not reported1,03542%
- Status unknown54822%
- Ongoing43318%
- Stopped: other or unclear1406%
- Met its primary endpoint1255%
- Stopped: enrollment or feasibility783%
- Missed its primary endpoint512%
- Stopped: lack of efficacy141%
- Stopped: sponsor or business decision8<1%
- Stopped: funding4<1%
- Stopped: safety1<1%
| Apr 16, 2025 | Menopur and rekovelle combination study version 2.0Rekovelle (follitropin delta) / Menopur (menotropins) | Estée Lauder Companies | Ongoing |
| Sep 13, 2023 | Fsh and lh versus fsh alone for ovarian stimulation in non-hormone sensitive onco-fertility patients: a randomized controlled trialGonal-f pen / Luveris | Mount Sinai Hospital | Pending |
| Mar 15, 2023 | A phase 3, multicenter, randomized, double-blind, double-dummy, activecontrolled, non-inferiority study to investigate the efficacy and safety of a single…OG-8962 (corifollitropin alfa) / Follitropin beta 600 IU/0.72ML / Leuprolide… | Organon | Pending |
| Mar 15, 2023 | A phase 3, multicenter, randomized, double-blind, double-dummy,activecontrolled, non-inferiority study to investigate the efficacy and safety of a single…OG-8962 (corifollitropin alfa) / Follitropin beta 600 IU/0.72ML /leuprolide… | Organon | Pending |
| Sep 9, 2022 | Rescue progesterone supplementation in patients with low progesterone on the day of embryo transfer for modified natural cycles: a non-inferiority studyProgesterone / Acetylsalicylic acid | Estée Lauder Companies | Closed |
| Apr 1, 2021 | Probiotic and antibiotic therapies in women with unexplained infertilityMetronidazole | McMaster University | Ongoing |
| Feb 19, 2021 | Bariatric surgery for fertility-sparing treatment of atypical hyperplasia and grade 1 cancer of the endometrium (b-fierce)Levonorgestrel | University Health Network | Ongoing |
| Jul 5, 2019 | Effect of personalized dosages of rekovelle on the number of mature follicles reached in intra-uterine inseminationRekovelle (follitropin delta) / Endometrin (progesterone effervescent vaginal… | Estée Lauder Companies | Pending |
| Mar 28, 2018 | A pilot phase II, multicentre, open-label, randomized, controlled study of the efficacy and safety of controlled ovarian stimulation with fixed induction timeLuveris / Gonal-f / Estrace | The Montreal Fertility Center | Closed |
| Oct 6, 2015 | Dopamine D-2 antagonist use in poor responders in ivf: a randomized controlled trialMetoclopramide | Toronto Centre for Advanced Reproductive Technology | Pending |
| May 24, 2000 | Gonal-FFor the induction of spermatogenesis in men with primary and secondary hypogonadotropic hypogonadism in whom the cause of infertility is… | EMD Serono, Inc. | Approved |
| Feb 1, 2019 | Autologous adult bone marrow-derived and unexpanded CD133+…Treatment of women with infertility and a thin endometrium seeking pregnancy | Asherman Therapy S.L.U. | Designated |
| Feb 13, 1990 | Sermorelin acetateAdjunct to gonadotropin therapy in the induction of ovulation in women with anovulatory or oligo-ovulatory infertility who fail to ovulate… | EMD Serono, Inc. | Designated |
| Sep 1, 1987 | SomatropinAdjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or… | Novo Nordisk Pharmaceuticals | Designated |
| Jun 25, 2007 | PergoverisFollitropin alfa; lutropin alfa | Merck Europe B.V. | EMA ↗ |
| May 2, 1996 | PuregonFollitropin beta | Organon N.V. | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA